InvestorsHub Logo
Followers 23
Posts 2760
Boards Moderated 0
Alias Born 02/23/2013

Re: None

Saturday, 03/08/2014 4:47:49 AM

Saturday, March 08, 2014 4:47:49 AM

Post# of 346654
RE: A Phase I/II IST evaluating bavituximab in combination with sorafenib in up to 48 patients with advanced hepatocellular carcinoma (liver cancer). A presentation of this trial will be made by Adam Yopp, M.D., Assistant Professor of Surgery at the University of Texas Southwestern Medical Center, Dallas, Texas as an oral presentation at the 2014 Society of Surgical Oncology Cancer Symposium on March 13, 2014.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News